Date of report (Date of earliest event reported): March 7, 2024
|
||
Perspective Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
||
Delaware
(State or Other Jurisdiction of Incorporation) |
001-33407
(Commission File Number) |
41-1458152
(IRS Employer Identification No.) |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value
|
CATX
|
NYSE American
|
Item 8.01
|
Other Events. |
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
99.1 | Corporate Presentation |
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Exhibit 99.1